Cross Shore Discovery Fund | |||||||||||||
Schedule of Investments | |||||||||||||
June 30, 2022 | |||||||||||||
(Unaudited) | |||||||||||||
Next | |||||||||||||
Initial | Available | ||||||||||||
% of | Acquisition | Redemption | Redemption | ||||||||||
Portfolio Funds* | Net Assets | Cost(1) | Fair Value | Date | Frequency(2) | Date | |||||||
Long/Short Generalist: | |||||||||||||
Atika Offshore Fund, Ltd., Class A, Series 1 | 10.1% | $ 1,440,187 | $ 3,881,678 | 1/2/2015 | Quarterly | 9/30/2022 | |||||||
EVR Offshore Partners Fund, Ltd., Class B, Series 1121 | 4.8% | 1,750,000 | 1,838,111 | 11/1/2021 | Quarterly | 9/30/2022 | (3)(4) | ||||||
Hawk Ridge Partners Offshore, Ltd., Class A, Initial Series | 6.3% | 1,600,000 | 2,445,561 | 2/1/2018 | Quarterly | 9/30/2022 | |||||||
Hill City Capital Offshore Fund Ltd., Class A, Series 14 | 5.0% | 1,750,000 | 1,925,963 | 11/1/2021 | Quarterly | 9/30/2022 | (4)(7) | ||||||
Rip Road Offshore Fund Ltd., Class E-1A, Series I00015782 | 1.1% | 750,000 | 411,913 | 8/1/2020 | Quarterly | 9/30/2022 | (4) | ||||||
Rivulet Capital Offshore Fund, Ltd., Class A, Series 1 | 1.3% | 366,993 | 518,338 | 6/1/2015 | Quarterly | 9/30/2022 | (4) | ||||||
Stony Point Capital Partners Offshore Ltd., Founders Class, Series 2020-08 | 0.8% | 500,000 | 301,012 | 8/1/2020 | Quarterly | 9/30/2022 | (4) | ||||||
TCIM Offshore Fund Ltd., Class A-33, Series 2019-12 | 6.0% | 1,756,890 | 2,317,513 | 12/1/2019 | Monthly | 7/31/2022 | |||||||
Thames Absolute Return Offshore Fund, Ltd., Class B-2, Series 1 | 5.5% | 1,550,000 | 2,130,652 | 11/1/2017 | Quarterly | 9/30/2022 | |||||||
Wolf Hill Offshore Fund, Ltd., Class A-OS, Series 2021-07 | 3.3% | 1,300,000 | 1,256,102 | 7/1/2021 | Quarterly | 9/30/2022 | |||||||
Total Long/Short Generalist | 44.2% | 12,764,070 | 17,026,843 | ||||||||||
Long/Short Sector: | |||||||||||||
Energy | |||||||||||||
Encompass Capital Fund Offshore Ltd., Class A, Series 1 | 8.3% | 1,900,000 | 3,201,300 | 1/1/2020 | Quarterly | 9/30/2022 | |||||||
Financial Services | |||||||||||||
BHZ Consolidation Cayman Fund, LP, Class C | 5.9% | 1,950,000 | 2,266,282 | 5/1/2018 | Quarterly | 9/30/2022 | |||||||
Healthcare, Biotechnology | |||||||||||||
Avoro Life Sciences Offshore Fund Ltd., Class A-1 | 9.3% | 1,200,000 | 3,589,916 | 5/1/2017 | Quarterly | 9/30/2022 | |||||||
Biomedical Offshore Value Fund, Ltd., Class I, Series 200199-1 | 7.1% | 2,100,000 | 2,726,905 | 1/1/2019 | Quarterly | 9/30/2022 | |||||||
Total Healthcare, Biotechnology | 16.4% | 3,300,000 | 6,316,821 | ||||||||||
Healthcare, Consumer | |||||||||||||
Armistice Capital Offshore Fund Ltd., Class A, Series 2019-04B | 0.0% | (5) | 17,040 | 4,579 | 4/1/2019 | N/A | (6) | ||||||
Armistice Capital Offshore Fund Ltd., Class A, Series 2015-09B | 0.0% | (5) | 4,503 | 2,148 | 9/1/2015 | N/A | (6) | ||||||
Armistice Capital Offshore Fund Ltd., Class A, Series 2013-08B | 0.0% | (5) | 3,108 | 1,627 | 1/2/2015 | N/A | (6) | ||||||
Total Armistice Capital Offshore Fund, Ltd. | 0.0% | (5) | 24,651 | 8,354 | |||||||||
Technology, Media and Telecommunications | |||||||||||||
Atreides Foundation Fund, Ltd., Founders Class, Series F-2 | 5.5% | 1,585,524 | 2,131,451 | 5/15/2019 | Quarterly | 9/30/2022 | (4) | ||||||
Center Lake Capital, Ltd., Class A, Initial Series | 4.3% | 1,850,000 | 1,648,422 | 5/1/2019 | Semi-Annual | 12/31/2022 | |||||||
Total Technology, Media and Telecommunications | 9.8% | 3,435,524 | 3,779,873 | ||||||||||
Total Long/Short Sector | 40.4% | 10,610,175 | 15,572,630 | ||||||||||
Total Investments In Portfolio Funds | 84.6% | $ 23,374,245 | $ 32,599,473 | ||||||||||
% of | |||||||||||||
Money Market Funds | Net Assets | Cost | Fair Value | Shares | |||||||||
Federated Hermes Institutional Prime Obligations Fund, | |||||||||||||
Institutional Class, 1.44%(8) | 9.1% | $ 3,505,718 | $ 3,504,199 | 3,505,250 | |||||||||
Total Investments | 93.7% | $ 26,879,963 | $ 36,103,672 | ||||||||||
Other Assets in Excess of Liabilities | 6.3% | $ 2,438,044 | |||||||||||
Net Assets | 100.0% | $ 38,541,716 | |||||||||||
* Non-income producing security. | |||||||||||||
(1) There were no unfunded capital commitments as of June 30, 2022. | |||||||||||||
(2) Certain redemptions may be subject to various restrictions and limitations such as redemption penalties on investments liquidated within a certain period subsequent to investment (e.g., a soft or hard lock-up), investor-level gates and/or Portfolio Fund-level gates. Redemption notice periods range from 30 to 120 days. | |||||||||||||
(3) Subject to hard lock through March 31, 2023. | |||||||||||||
(4) Subject to 25% investor level quarterly gate. | |||||||||||||
(5) Amount is less than 0.05%. | |||||||||||||
(6) Redemptions are not permitted until the underlying special investments are sold/liquidated. | |||||||||||||
(7) Subject to hard lock through December 31, 2022. | |||||||||||||
(8) Rate disclosed is the seven day effective yield as of June 30, 2022. |
- XDSCX Dashboard
- Filings
- Insider
-
NPORT-P Filing
Cross Shore Discovery Fund (XDSCX) NPORT-PCross Shore Discovery Fund (Jun 2022 report)
Filed: 29 Aug 22, 9:26am